Cargando…

Plasmatic MicroRNAs and Treatment Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer: A Hospital-Based Cohort Study and In Silico Analysis

Prostate cancer (PCa) is one of the most common malignancies among men worldwide. Inevitably, all advanced PCa patients develop metastatic castration-resistant prostate cancer (mCRPC), an aggressive phase of the disease. Treating mCRPC is challenging, and prognostic tools are needed for disease mana...

Descripción completa

Detalles Bibliográficos
Autores principales:	Silva, Jani, Tavares, Valéria, Afonso, Ana, Garcia, Juliana, Cerqueira, Fátima, Medeiros, Rui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219330/ https://www.ncbi.nlm.nih.gov/pubmed/37240449 http://dx.doi.org/10.3390/ijms24109101

Ejemplares similares

Insights into the Role of Plasmatic and Exosomal microRNAs in Oxidative Stress-Related Metabolic Diseases
por: Duisenbek, Ayauly, et al.
Publicado: (2023)

MicroRNAs as Potential Liquid Biopsy Biomarker for Patients with Castration-Resistant Prostate Cancer
por: Fernandez, Nicolas, et al.
Publicado: (2022)

MicroRNAs Associated with Metastatic Prostate Cancer
por: Watahiki, Akira, et al.
Publicado: (2011)

MicroRNA determinants of neuroendocrine differentiation in metastatic castration-resistant prostate cancer
por: Bhagirath, Divya, et al.
Publicado: (2020)

Plasmatic and myocardial microRNA profiles in patients with Hypertrophic Cardiomyopathy
por: Lombardi, Maria, et al.
Publicado: (2021)

MicroRNA-like snoRNA-Derived RNAs (sdRNAs) Promote Castration-Resistant Prostate Cancer
por: Coley, Alexander B., et al.
Publicado: (2022)

Circulating microRNAs are associated with docetaxel chemotherapy outcome in castration-resistant prostate cancer
por: Lin, H-M, et al.
Publicado: (2014)

Diagnostic Potential of Plasmatic MicroRNA Signatures in Stable and Unstable Angina
por: D'Alessandra, Yuri, et al.
Publicado: (2013)

Differentially expressed plasmatic microRNAs in Brazilian patients with Coronavirus disease 2019 (COVID-19): preliminary results
por: Nicoletti, Aline de Souza, et al.
Publicado: (2022)

New combined microRNA and protein plasmatic biomarker panel for pancreatic cancer
por: Yuan, Wei, et al.
Publicado: (2016)

The Role of MicroRNAs in the Metastatic Process of High-Risk HPV-Induced Cancers
por: Santos, Joana M.O., et al.
Publicado: (2018)

In silico characterization of microRNAs-like sequences in the genome of Paracoccidioides brasiliensis
por: de Curcio, Juliana S., et al.
Publicado: (2019)

MicroRNAs in prostate cancer
por: Kim, Won Tae, et al.
Publicado: (2012)

microRNAs and prostate cancer
por: Shi, Xu-Bao, et al.
Publicado: (2008)

Association of Androgenic Regulation and MicroRNAs in Acinar Adenocarcinoma of Prostate
por: Bernardes, Julio Guilherme Balieiro, et al.
Publicado: (2022)

The microRNA -23b/-27b Cluster Suppresses the Metastatic Phenotype of Castration-Resistant Prostate Cancer Cells
por: Ishteiwy, Reema A., et al.
Publicado: (2012)

Diet, MicroRNAs and Prostate Cancer
por: Saini, Sharanjot, et al.
Publicado: (2010)

Plasma miRNAs as Biomarkers to Identify Patients with Castration-Resistant Metastatic Prostate Cancer
por: Watahiki, Akira, et al.
Publicado: (2013)

Targeting the Metastatic Bone Microenvironment by MicroRNAs
por: Haider, Marie-Therese, et al.
Publicado: (2018)

Screening key microRNAs for castration-resistant prostate cancer based on miRNA/mRNA functional synergistic network
por: Zhu, Jin, et al.
Publicado: (2015)

In silico Analysis of Polymorphisms in microRNAs Deregulated in Alzheimer Disease
por: Moraghebi, Mahta, et al.
Publicado: (2021)

In silico and in vitro analysis of microRNAs with therapeutic potential in atherosclerosis
por: Mahjoubin-Tehran, Maryam, et al.
Publicado: (2022)

MicroRNAs in kidney development and disease
por: Cerqueira, Débora Malta, et al.
Publicado: (2022)

The Multifaceted Roles of MicroRNAs in Cystic Fibrosis
por: De Palma, Fatima Domenica Elisa, et al.
Publicado: (2020)

Computational identification of mutually exclusive transcriptional drivers dysregulating metastatic microRNAs in prostate cancer
por: Xue, Mengzhu, et al.
Publicado: (2017)

The role of microRNAs in prostate cancer progression
por: Lo, U-Ging, et al.
Publicado: (2013)

Targeting MicroRNAs in Prostate Cancer Radiotherapy
por: Ni, Jie, et al.
Publicado: (2017)

Role of MicroRNAs in Neuroendocrine Prostate Cancer
por: Sreekumar, Amritha, et al.
Publicado: (2022)

Phase 2 study of circulating microRNA biomarkers in castration-resistant prostate cancer
por: Lin, Hui-Ming, et al.
Publicado: (2017)

Utilization and Outcomes of Surgical Castration in Comparison to Medical Castration in Metastatic Prostate Cancer
por: Garje, Rohan, et al.
Publicado: (2019)

Plasmatic extracellular vesicle microRNAs in malignant pleural mesothelioma and asbestos-exposed subjects suggest a 2-miRNA signature as potential biomarker of disease
por: Cavalleri, Tommaso, et al.
Publicado: (2017)

The Emerging Role of MicroRNAs and Other Non-Coding RNAs in Cancer Cachexia
por: Santos, Joana M. O., et al.
Publicado: (2020)

Plasmatic exosome-derived circRNAs panel act as fingerprint for glioblastoma
por: Xia, Dongyan, et al.
Publicado: (2021)

MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer
por: Ghamlouche, Fatima, et al.
Publicado: (2023)

In silico prediction of cellular gene targets of herpesvirus encoded microRNAs
por: Naqvi, Afsar R., et al.
Publicado: (2018)

Impact of Time to Castration Resistance on Cytoreductive Radiotherapy in Metastatic Castration-Resistant Prostate Cancer
por: Mai, Lixin, et al.
Publicado: (2020)

Androgen receptor-mediated downregulation of microRNA-221 and -222 in castration-resistant prostate cancer
por: Gui, Bin, et al.
Publicado: (2017)

Drug resistance in metastatic castration-resistant prostate cancer: an update on the status quo
por: Yehya, Amani, et al.
Publicado: (2022)

Evaluation of the plasmatic level of mepivacaine in different anatomical regions
por: Ferreira, Jéssica-Caroline-Afonso, et al.
Publicado: (2018)

Radium-223 in metastatic castration resistant prostate cancer
por: Vuong, Winston, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hva2j5i9fp2gelhoir5msoijdg